Amira A. Shaheen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amira A. Shaheen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Hebatallah A. Darwish
Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt
2 shared publications - Mae M. Seleem
Pharmacology, Toxicology and Biochemistry Department, Faculty of Pharmacy, Future University in Egypt (FUE), Cairo, Egypt
2 shared publications - Ashraf A. Shamaa
Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt
1 shared publication - Aya A. Zayed
Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt
1 shared publication - Hebat Allah Ahmed Amin
Pathology Department, Faculty of Medicine, Helwan University, Cairo, Egypt
1 shared publication - Laila Ahmed Rashed
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo 12613, Egypt
1 shared publication
Latest Publications
- 15 October 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 296
Potential Role of Zn Supplementation in Ameliorating Reserpine-Induced Fibromyalgia Manifestations Through Central NLRP3–Autophagy-Redox Network Modulation in Rats
- 15 October 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 296
Potential Role of Zn Supplementation in Ameliorating Reserpine-Induced Fibromyalgia Manifestations Through Central NLRP3–Autophagy-Redox Network Modulation in Rats
- 12 October 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 331, 148270
Role of lncRNAs H19, KCNQ1OT1 and SRA in relation to peroxisome proliferator-activated receptor gamma in the occurrence and progression of non-alcoholic fatty pancreas disease in obese and non-obese Egyptian patients
- 12 October 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 331, 148270
Role of lncRNAs H19, KCNQ1OT1 and SRA in relation to peroxisome proliferator-activated receptor gamma in the occurrence and progression of non-alcoholic fatty pancreas disease in obese and non-obese Egyptian patients
- Open Access
- 20 February 2023
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (4) , 1193-1204
Role of long noncoding RNAs; BDNF-AS and 17A and their relation to GABAergic dysfunction in Egyptian epileptic patients
Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures. Lately, long noncoding RNAs (lncRNAs) have been increasingly appreciated as regulators of epilepsy-related processes, however, their functional role in its pathogenesis is still to be explored. This study investigated the expression levels of lncRNAs; BDNF-AS and 17A in the sera of Egyptian patients with idiopathic generalized and symptomatic focal epilepsy and correlated their levels with brain-derived neurotrophic factor (BDNF), phosphorylated cAMP reaction element -binding protein (p-CREB), gamma- aminobutyric acid (GABA) and glutamate, to underline their related molecular mechanism. A total of 70 epileptic patients were divided into two clinical types, besides 30 healthy controls of matched age and sex. The expression levels of both lncRNAs were markedly upregulated in epileptic groups versus the healthy control group with predominance in the symptomatic focal one. Epileptic patients showed significantly lower levels of BDNF, p-CREB, GABA along with significant increase of glutamate levels and glutamate/ GABA ratio, especially in symptomatic focal versus idiopathic generalized epileptic ones. The obtained data raised the possibility that these lncRNAs might be involved in the pathogenesis of epilepsy via inhibition of GABA/p-CREB/BDNF pathway. The study shed light on the putative role of these lncRNAs in better diagnosis of epilepsy, particularly symptomatic focal epilepsy.
- 20 February 2023
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (4) , 1193-1204
Open AccessRole of long noncoding RNAs; BDNF-AS and 17A and their relation to GABAergic dysfunction in Egyptian epileptic patients
Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures. Lately, long noncoding RNAs (lncRNAs) have been increasingly appreciated as regulators of epilepsy-related processes, however, their functional role in its pathogenesis is still to be explored. This study investigated the expression levels of lncRNAs; BDNF-AS and 17A in the sera of Egyptian patients with idiopathic generalized and symptomatic focal epilepsy and correlated their levels with brain-derived neurotrophic factor (BDNF), phosphorylated cAMP reaction element -binding protein (p-CREB), gamma- aminobutyric acid (GABA) and glutamate, to underline their related molecular mechanism. A total of 70 epileptic patients were divided into two clinical types, besides 30 healthy controls of matched age and sex. The expression levels of both lncRNAs were markedly upregulated in epileptic groups versus the healthy control group with predominance in the symptomatic focal one. Epileptic patients showed significantly lower levels of BDNF, p-CREB, GABA along with significant increase of glutamate levels and glutamate/ GABA ratio, especially in symptomatic focal versus idiopathic generalized epileptic ones. The obtained data raised the possibility that these lncRNAs might be involved in the pathogenesis of epilepsy via inhibition of GABA/p-CREB/BDNF pathway. The study shed light on the putative role of these lncRNAs in better diagnosis of epilepsy, particularly symptomatic focal epilepsy.
- Open Access
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108584
Hydrogen sulfide enhances the effectiveness of mesenchymal stem cell therapy in rats with heart failure: In vitro preconditioning versus in vivo co-delivery
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108584
Open AccessHydrogen sulfide enhances the effectiveness of mesenchymal stem cell therapy in rats with heart failure: In vitro preconditioning versus in vivo co-delivery